Last checked at 17 Feb 2009 16:00
| For filings with the FSA include the annex For filings with issuer exclude the annex |
| TR-1: Notifications of Major Interests in Shares |
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Phytopharm plc |
| 2. Reason for notification (yes/no) | |
| An acquisition or disposal of voting rights | X |
| An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |
| An event changing the breakdown of voting rights | |
| Other (please specify):______________ | |
| 3. Full name of person(s) subject to notification obligation: | AXA S.A>, 25 Avenue Matignon, 75008 Paris and its group of companies |
| 4. Full name of shareholder(s) (if different from 3): | |
| 5. Date of transaction (and date on which the threshold is crossed or reached if different): | 12/02/2009 |
| 6. Date on which issuer notified: | 13/02/2009 |
| 7. Threshold(s) that is/are crossed or reached: | 5% |
| 8: Notified Details | |||||||
| A: Voting rights attached to shares | |||||||
| Class/type of shares If possible use ISIN code | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | |||||
| Number of shares | Number of voting rights | Number of shares | Number of voting rights | Percentage of voting rights | |||
| Direct | Indirect | Direct | Indirect | ||||
| 0686972 | 5,561,706 | 5,561,706 | 4,289,912 | 11,000 | 4,278,912 | 0.01 | 4.53 |
| B: Financial Instruments | ||||
| Resulting situation after the triggering transaction | ||||
| Type of financial instrument | Expiration date | Exercise/ conversion period/date | No. of voting rights that may be acquired (if the instrument exercised/converted) | Percentage of voting rights |
| Total (A+B) | |
| Number of voting rights | Percentage of voting rights |
| 4,289,912 | 4.54 |
| 9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: |
| Name of the Company / Fund Number of shares % of issued share capital AXA Framlington 4,278,912 4.52563% Indirect AXA IM UK 11,000 0.01163% Direct Total Direct 11,000 0.01163% Total Indirect 4,278,912 4.52563% TOTAL 4,289,912 4.53727% |
| Proxy Voting: | |
| 10. Name of proxy holder: | |
| 11. Number of voting rights proxy holder will cease to hold: | |
| 12. Date on which proxy holder will cease to hold voting rights: | |
| 13. Additional information: | |
| 14 Contact name: | Zoe McGowan |
| 15. Contact telephone number: | 01480 437697 |
For notes on how to complete form TR-1 please see the FSA website.